CLINICAL / SCIENTIFIC PRESENTATION AND PUBLICATION HIGHLIGHTS
The information contained in each post on this page was factually accurate on the date it was issued and posted.
STRO-001 – Publication Highlights
Pan Pacific Lymphoma, 2018 HIGH FREQUENCY OF CD74 EXPRESSION IN B-CELL NON-HODGKIN’S LYMPHOMA (NHL) AND TARGETING WITH STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC) WITH POTENT IN VITROCYTOTOXICTY AND IN VIVOANTI-TUMOR ACTIVITY A Yu1, C Abrahams1, M...
Science and Platform Publication Highlights
Biotechnol Bioeng. 2011 Jul;108(7):1570-8. doi: 10.1002/bit.23103. Epub 2011 Mar 31. Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines. Zawada JF, Yin G, Steiner AR, Yang J,...
American Society of Hematology (ASH) 2017 – Oral Presentation
High Frequency of CD74 Expression in B-cell Non-Hodgkin’s Lymphoma (NHL) and Targeting with STRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent In Vitro Cytotoxicity and In Vivo Anti-Tumor Activity 2017 ASH NHL Oral Presentation_2017 FINAL
American Association for Cancer Research (AACR) 2017 – Poster
Characterization and pre-clinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies 2017 combined MM and NHL AACR FINAL
American Society of Hematology (ASH) 2016 – NHL Oral Presentation
Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin’s Lymphoma Arturo Molina, MD, MS Sutro Biopharma ASH Annual Meeting 2016 ASH NHL Oral Presentation_120316 SLM
American Society of Hematology (ASH) 2016 – Poster
Discovery and preclinical development of novel CD74-targeting antibody-drug conjugates (ADCs) with significant activity in multiple myeloma (MM) cell lines and xenograft models 2016 DEC ASH MM Poster final no logo
Production of Bispecific Antibodies in “Knobs-Into-Holes” Using a Cell-Free Expression System
Yiren Xu, John Lee, Cuong Tran, Tyler H Heibeck, Willie D Wang, Junhao Yang, Ryan L Stafford, Alexander R Steiner, Aaron K Sato, Trevor J Hallam, and Gang Yin, Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system mAbs 7:1,...
Methods to Make Homogenous Antibody Drug Conjugates
Toni Kline, Alexander R. Steiner, Kalyani Penta, Aaron K. Sato, Trevor J. Hallam, Gang Yin, Methods to Make Homogenous Antibody Drug Conjugates Pharmaceutical Research December 2014, Read more
A General Sequence Processing and Analysis Program for Protein Engineering
Ryan L. Stafford,* Erik S. Zimmerman, Trevor J. Hallam, and Aaron K. Sato, A General Sequence Processing and Analysis Program for Protein Engineering, dx.doi.org/10.1021/ci500362s | J. Chem. Inf. Model. PDF Read More
World ADC Summit 2013 – Dual-Warhead Antibody Drug Conjugate
SAN FRANCISCO, Oct. 15, 2013 - Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis technology, presented today the first data involving a dual-warhead antibody drug conjugate...